Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
18384253 |
Age 24.5 ± 3, Gender ⚥ |
0.96 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 40.8 ± 5.6, Gender ⚥ |
1.02 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 55.6 ± 3.7, Gender ⚥ |
1.05 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
24457528 |
Age 100.7 ± 2.1, Gender ⚥ |
8.29 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 70 ± 6, Gender ⚥ |
6.53 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 100.7 ± 2.1, Gender ♀ |
8.23 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 70 ± 6, Gender ♀ |
6.48 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 100.7 ± 2.1, Gender ♂ |
8.48 (mean of regulated metabolite) |
H-NMR |
serum |
24457528 |
Age 70 ± 6, Gender ♂ |
6.59 (mean of regulated metabolite) |
H-NMR |
serum |
12768504 |
Age 32.6 ± 4.4 , Gender ♀ |
60.0 (μmol/l) |
LC |
blood |
12768504 |
Age 48 ± 4.3, Gender ♀ |
60.0 (μmol/l) |
LC |
blood |
12768504 |
Age 74.7 ± 10, Gender ♀ |
58.0 (μmol/l) |
LC |
blood |
12768504 |
Age 33.3 ± 3.8, Gender ♂ |
76.0 (μmol/l) |
LC |
blood |
12768504 |
Age 48.4 ± 6, Gender ♂ |
67.0 (μmol/l) |
LC |
blood |
12768504 |
Age 75.9 ± 9.3, Gender ♂ |
61.0 (μmol/l) |
LC |
blood |
30113646 |
Age 44.6 ± 13, Gender ♀ (South-Asian Surinamese) |
53.8 (μmol/L) |
LC-MS/MS |
plasma |
30113646 |
Age 44.6 ± 13, Gender ♀ (South-Asian Surinamese) |
103.5 (% (percentage of metabolite concentration compared with baseline (100%) per 10 year increment in age; analyses were adjusted for BMI)) |
LC-MS/MS |
plasma |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |